CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for MediBIc Group is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

MediBIc Group
5F, Rohto Tokyo Bldg., 1-7-5, Shiba
Phone: +81 354399691p:+81 354399691 MINATO-KU, TKY  105-0014  Japan Ticker: 23692369
Business Summary
MediBIC Group is a Japan-based company comprised of four business segments. The Biomarker Drug Discovery Supports segment provides support solution services for new drug development, including the provision of analytical, clinical trial coordinate, data analytical and pharmacogenomics (PGx) test support services, as well as the sale of development support products and system architecture business. The Tailor-made Healthcare Management Supports segment provides private deoxypentose nucleic acid (DNA) bank services and other health support services. The Drug Discovery segment adds value to candidate compounds of genomic, advanced and general new drugs to acquire part of intellectual properties. The Investment and Incubation segment is engaged in the management and operation of funds, and the trading of securities.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/201612/31/2015Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Representative Director HajimeKuboshima 3/29/2016
Executive Officer, Chief Director of Administration YutakaKadoi 49 9/1/2008
Executive Officer YujiAriyoshi 8/1/2008 8/1/2008
4 additional Officers and Directors records available in full report.

Business Names
Business Name
2369
AnimalStemCell
MediBIC
MediBIC Group
Site Quality Co., Ltd.

General Information
Number of Employees: 17 (As of 12/31/2015)
Outstanding Shares: 29,408,020 (As of 6/30/2016)
Shareholders: 11,157
Stock Exchange: TYO
Fax Number: +81 354399696


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, August 30, 2023